Newway (300765.SZ) Subsidiary's SIRUKIYO Monoclonal Antibody Injection Phase III Clinical Trial Obtains Topline Analysis Data

Cnfol app news, Xinnorway (300765.SZ) announced that its controlling subsidiary, Synergy Biopharmaceuticals Limited (referred to as "Synergy Biopharmaceuticals"), has recently obtained top-line analysis data in the Phase III clinical trial of its Sijiqiu Monoclonal Antibody Injection.